Mechanistically, this was linked to a BCR-ABL-dependent regulatory feedback mechanism that posttranslationally stimulates Separase proteolytic activity after IM-induced decreases of Separase expression in b3a2 BCR-ABL fusion type CML cell lines [35]. The gene discussed is ESPL1; the disease is chronic myelogenous leukemia, BCR-ABL1 positive.